Origin of the fourth component of complement related Chido and Rodgers blood group antigens
- PMID: 2967744
- DOI: 10.1159/000463037
Origin of the fourth component of complement related Chido and Rodgers blood group antigens
Abstract
We have reviewed the relationship between C4 and its related blood group and discussed the mechanisms whereby a fragment of C4 could become attached to erythrocytes (E). We hypothesize that there is chronic fluid-phase activation of C4 by either C1 to form C4b or spontaneous cleavage of the thioester to form iC4. These activated molecules bind to E. Proteolytic degradation of the bound C4b or iC4 would leave a covalently attached fragment of C4 on E and thereby give rise to the Ch and Rg blood group antigens. This system is of further immunopathologic interest since this 'normal' activation or turnover of C4 is closely regulated. In patients deficient in regulatory proteins, this spontaneous or normal turnover of C4 and C3 may initiate a pathologic condition.
Similar articles
-
In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.Transfusion. 1991 Mar-Apr;31(3):222-8. doi: 10.1046/j.1537-2995.1991.31391165171.x. Transfusion. 1991. PMID: 1706118
-
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.J Immunol. 1984 Jun;132(6):3019-27. J Immunol. 1984. PMID: 6609966
-
Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.J Immunol. 1984 Nov;133(5):2634-40. J Immunol. 1984. PMID: 6207239
-
Antigenic determinants of human C4, Rodgers and Chido.Exp Clin Immunogenet. 1988;5(2-3):99-114. Exp Clin Immunogenet. 1988. PMID: 2483343 Review.
-
A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.Immunogenetics. 1988;27(6):399-405. doi: 10.1007/BF00364425. Immunogenetics. 1988. PMID: 2453459 Review. No abstract available.
Cited by
-
New advances in measurement of complement activation: lessons of systemic lupus erythematosus.Curr Rheumatol Rep. 2004 Oct;6(5):375-81. doi: 10.1007/s11926-004-0012-5. Curr Rheumatol Rep. 2004. PMID: 15355750 Review.
-
Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside.Rheum Dis Clin North Am. 2010 Feb;36(1):161-72, x. doi: 10.1016/j.rdc.2009.12.003. Rheum Dis Clin North Am. 2010. PMID: 20202597 Free PMC article.
-
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.Arthritis Rheum. 2010 Mar;62(3):837-44. doi: 10.1002/art.27267. Arthritis Rheum. 2010. PMID: 20187154 Free PMC article.
-
Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.Immunobiology. 2021 May;226(3):152093. doi: 10.1016/j.imbio.2021.152093. Epub 2021 May 9. Immunobiology. 2021. PMID: 34022670 Free PMC article.
-
Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future.Curr Rheumatol Rep. 2004 Apr;6(2):85-8. doi: 10.1007/s11926-004-0046-8. Curr Rheumatol Rep. 2004. PMID: 15016335 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous